| abstract |
The present invention relates to tetrahydrobenzo-isoquinoline sulfonamide derivatives of formula (I), processes for their preparation, pharmaceutical compositions comprising them and their use in the treatment of IgE-induced disorders (eg allergic reactions, non-allergic reactions) mast cell responses or certain autoimmune responses) and in particular disorders caused by the interaction of IgE with FcεRI receptors. |